News on Peripheral T-cell lymphoma

被引：0
|
作者：
Alexander Pichler
机构：
[1] Anna Spiegel Center of Translational Research ASCTR,Department of Medicine I, Division of Hematology and Hemostaseology
[2] Medical University of Vienna,undefined
来源：
memo - Magazine of European Medical Oncology | 2023年 / 16卷
关键词：
T‑cell lymphoma; Treatment; WHO subtypes; Brentuximab vedotin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Peripheral T‑cell lymphomas (PTCL) are a heterogeneous group of rare lymphoid malignancies. Brentuximab vedotin plus cyclophosphamide, doxorubicin, and prednisone (BV+CHP, anti-CD30) is indicated as first-line treatment in the subgroup anaplastic large cell lymphoma (ALCL). Romidepsin plus cyclophosphamide, doxorubicin, vincristine, and prednisone (Ro-CHOP) is inferior to CHOP in PTCL; however, the subtype angioimmunoblastic T‑cell lymphoma (AITL) might favor Ro-CHOP. An increase of survival after consolidation with autologous stem cell transplantation (ASCT) in first line was found in a retrospective analysis. New antibody (anti-CD47 or anti-KIR3DL2) and CAR T/NK treatments are emerging and entering clinical trials.
引用
收藏
页码：17 / 20
页数：3
相关论文
共 50 条
  • [1] News on Peripheral T-cell lymphoma
    Pichler, Alexander
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (01) : 17 - 20
  • [2] PERIPHERAL T-CELL LYMPHOMA
    BOEHRINGER, B
    OSTRONOFF, M
    MACEDO, MCA
    CONCHON, M
    MEDEIROS, RS
    MASSUMOTO, CM
    DULLEY, F
    MENEZES, Y
    VASALO, J
    LLACCER, PD
    POZZI, D
    CHAMONE, DF
    BLOOD, 1994, 84 (10) : A639 - A639
  • [3] Peripheral T-cell lymphoma
    Cookson, Emma
    LANCET HAEMATOLOGY, 2021, 8 (01): : E17 - E17
  • [4] PERIPHERAL T-CELL LYMPHOMA
    LIANG, R
    TODD, D
    CHAN, TK
    WONG, KL
    HO, F
    LOKE, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 750 - 755
  • [5] Peripheral T-cell lymphoma
    Foss, Francine M.
    Zinzani, Pier Luigi
    Vose, Julie M.
    Gascoyne, Randy D.
    Rosen, Steven T.
    Tobinai, Kensei
    BLOOD, 2011, 117 (25) : 6756 - 6767
  • [6] Peripheral T-cell lymphoma
    Canellos, GP
    ANNALS OF ONCOLOGY, 1998, 9 : 2 - 2
  • [7] PERIPHERAL T-CELL LYMPHOMA
    ARMITAGE, JO
    GREER, JP
    LEVINE, AM
    WEISENBURGER, DD
    FORMENTI, SC
    BAST, M
    CONLEY, S
    PIERSON, J
    LINDER, J
    COUSAR, JB
    NATHWANI, BN
    CANCER, 1989, 63 (01) : 158 - 163
  • [8] PERIPHERAL T-CELL LYMPHOMA
    WATANABE, S
    MUKAI, K
    SHIMOYAMA, M
    CANCER AND METASTASIS REVIEWS, 1988, 7 (03) : 243 - 261
  • [9] PERIPHERAL T-CELL LYMPHOMA
    CLERICI, T
    BACHELEZ, H
    BAGOT, M
    WECHSLER, J
    ZELLER, J
    HAIOUN, C
    KUENTZ, M
    ENNI, T
    TOURAINE, R
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1987, 114 (11): : 1364 - 1366
  • [10] Molecular pathogenesis of peripheral T-cell lymphoma (1): angioimmunoblastic T-cell lymphoma, peripheral T-cell lymphoma, not otherwise specified and anaplastic large cell lymphoma
    Couronne, Lucile
    Bastard, Christian
    Gaulard, Philippe
    Hermine, Olivier
    Bernard, Olivier
    M S-MEDECINE SCIENCES, 2015, 31 (10): : 843 - 854
12345